Standout Papers

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, ra... 2018 2026 2020 2023 218
  1. Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study (2018)
    Florence Duffaud, Olivier Mir et al. The Lancet Oncology

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes
2024 Standout
2 intermediate papers

Works of Emmanuelle Bompas being referenced

PD1 inhibition in soft-tissue sarcomas with tertiary lymphoid structures: A multicenter phase II trial.
2021
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas
2017

Author Peers

Author Last Decade Papers Cites
Emmanuelle Bompas 3990 2560 677 1142 193 5.6k
Scott H. Okuno 3486 2482 740 987 177 5.7k
Narasimhan P. Agaram 3648 2328 1257 677 108 6.2k
Kristen N. Ganjoo 3172 1907 988 594 170 5.1k
Elena Tamborini 3275 1739 698 439 142 5.5k
David R. D’Adamo 3144 2565 727 807 65 4.7k
Scott M. Schuetze 6220 3261 1344 1489 166 8.5k
Khin Thway 5068 2864 1422 1257 273 7.7k
Javier Martín‐Broto 3062 1582 531 540 227 4.3k
Louis Guillou 5654 2786 1585 1792 116 8.0k
Vivien Bramwell 2557 2374 633 505 74 5.0k

All Works

Loading papers...

Rankless by CCL
2026